Advances in the Clinical Management of Acute Myocardial Infarction
Journal: Journal of Clinical Medicine Research DOI: 10.32629/jcmr.v5i1.1777
Abstract
Acute myocardial infarction is a kind of cardiovascular disease mainly caused by coronary artery stenosis, atherosclerosis or blockage of myocardial cell hypoxia and ischemic necrosis, and it is one of the most hazardous cardiovascular diseases around the world. In recent years, the incidence of acute myocardial infarction has been increasing year by year in our country as well as the trend of rejuvenation, which has aroused the great importance of various medical experts. This has also caused various medical experts to pay great attention to the treatment of acute myocardial infarction in the clinic through the treatment of acute myocardial infarction to carry out continuous in-depth exploration, summarized some of the treatment of acute myocardial infarction effective methods. In this paper, the causes of acute myocardial infarction are elaborated, and the treatment plan of acute myocardial infarction is summarized, hoping to provide certain reference for clinical research.
Keywords
acute myocardial infarction, clinical management, therapeutic program
Full Text
PDF - Viewed/Downloaded: 1 TimesIndexation
Download Index RecordReferences
[1] ZHOU Weili, ZANG Shuting. Occurrence Characteristics and First Aid Measures of Cardiac Arrest Caused by Acute Myocardial Infarction Among Young and Middle-aged Patients[J]. Military Nursing. 2023;40(6):1-4. Doi: 10.3969/j.issn.2097-1826.2023.06.001.
[2] XU Jinfang, HAN Yayan, CHEN Juan, et al. Effect of applying remote ECG monitoring-based guidance for phase II cardiac rehabilitation after percutaneous coronary intervention for acute myocardial infarction[J]. Chinese Journal for Clinicians,2023;51(10):1167-1169. Doi: 10.3969/j.issn.2095-8552.2023.10.011.
[3] WAN Zunhui,WANG Zhenxia,ZHANG Cheng,et al. Study on related factors of slow blood flow or no reflow after emergency PCI for acute myocardial infarction[J]. China Journal of Modern Medicine. 2020;41(1):198-202. Doi: 10.3969/j.issn.1005-8982.2022.07.005.
[4] DING Yan-ling, LIANG Lun-chang, LIANG Mao-jin, et al. Comparison of the effect of different timing of percutaneous coronary intervention in patients with acute myocardial infarction[J]. Gansu Medical Journal. 2022;41(1):35-36,41. Doi: 0.15975/j.cnki.gsyy.2022.01.004.
[5] ZOU Huawei, ZHOU Jinfeng, ZHAO Yong, et al. Comparative study of clinical efficacy and cardiac function of emergency PCI and delayed PCI in patients with acute non － ST segment elevation myocardial infarction[J]. Journal of Clinical and Experimental Medicine. 2021;20(16):1692-1696. Doi: 10.3969/ j.issn.1671-4695.2021.16.004.
[6] Xie W, Hu LT, Chen HT, et al. Construction of prediction model of coronary slow flow/no reflow after percutaneous coronary intervention in patients with acute myocardial infarction[J]. Chinese Journal of Cardiovascular Research. 2023;21(9):858-864. Doi: 10.3969/j.issn.1672-5301.2023.09.016.
[7] LI Haipeng,ZHANG Jian. Two-year prognosis analysis of elderly patients with acute myocardial infarction after coronary artery bypass graft[J]. Chinese Journal of Multiple Organ Diseases in the Elderly. 2023;22(3):196-200. Doi: 10.11915. / j.issn.1641-5403.2023.03.040.
[8] ZHANG Xitao,SU Pixiong,LIU Yan,et al. Application of emergency coronary artery bypass grafting in acute myocardial infarction[J]. Chinese Journal of Emergency Medicine. 2005;14(4):319-322.
[9] LI Jing, CHENG Long, WANG Heyang, et al. Safety and efficacy of bivalirudin versus unfractionated heparin during perioperative period of percutaneous coronary intervention[J]. Chinese Journal of Cardiology. 2020;48(8):648-654. Doi: 10.3760/cma.j.cn112148-20200717-00566.
[10] Dai ZG. Comparison of effect of early thrombolysis and interventional therapy in acute myocardial infarction[J]. China Practical Medicine. 2023;18(4):1-4. Doi: 10.14163/j.cnki.11-5547/r.2023.04.001.
[11] LI Yanmin, FENG Yan, WEI Yanyun, et al. Predictive value of TRI,SII,CONUT score in the prognosis of acute myo-cardial infarction after percutaneous coronary intervention[J]. Journal of North Sichuan Medical College. 2023;38(7):906-909. Doi: 10.3969/j.issn.1005-3697.2023.07.009.
[12] Wang X. Analysis of the effect of aspirin combined with hydroclopidogrel on cardiac function and inflammatory response in patients with acute myocardial infarction[J]. Modern Diagnosis and Treatment. 2023;34(12):1807-1809.
[13] Gao Liansheng. Effect of aspirin and clopidogrel combined with tirofiban on the efficacy and adverse cardiovascular events in patients with diabetes mellitus with acute myocardial infarction[J]. Contemporary Medical Symposium. 2023,21(17):99-101. DOI:10.3969/j.issn.2095-7629.2023.17.030.
[2] XU Jinfang, HAN Yayan, CHEN Juan, et al. Effect of applying remote ECG monitoring-based guidance for phase II cardiac rehabilitation after percutaneous coronary intervention for acute myocardial infarction[J]. Chinese Journal for Clinicians,2023;51(10):1167-1169. Doi: 10.3969/j.issn.2095-8552.2023.10.011.
[3] WAN Zunhui,WANG Zhenxia,ZHANG Cheng,et al. Study on related factors of slow blood flow or no reflow after emergency PCI for acute myocardial infarction[J]. China Journal of Modern Medicine. 2020;41(1):198-202. Doi: 10.3969/j.issn.1005-8982.2022.07.005.
[4] DING Yan-ling, LIANG Lun-chang, LIANG Mao-jin, et al. Comparison of the effect of different timing of percutaneous coronary intervention in patients with acute myocardial infarction[J]. Gansu Medical Journal. 2022;41(1):35-36,41. Doi: 0.15975/j.cnki.gsyy.2022.01.004.
[5] ZOU Huawei, ZHOU Jinfeng, ZHAO Yong, et al. Comparative study of clinical efficacy and cardiac function of emergency PCI and delayed PCI in patients with acute non － ST segment elevation myocardial infarction[J]. Journal of Clinical and Experimental Medicine. 2021;20(16):1692-1696. Doi: 10.3969/ j.issn.1671-4695.2021.16.004.
[6] Xie W, Hu LT, Chen HT, et al. Construction of prediction model of coronary slow flow/no reflow after percutaneous coronary intervention in patients with acute myocardial infarction[J]. Chinese Journal of Cardiovascular Research. 2023;21(9):858-864. Doi: 10.3969/j.issn.1672-5301.2023.09.016.
[7] LI Haipeng,ZHANG Jian. Two-year prognosis analysis of elderly patients with acute myocardial infarction after coronary artery bypass graft[J]. Chinese Journal of Multiple Organ Diseases in the Elderly. 2023;22(3):196-200. Doi: 10.11915. / j.issn.1641-5403.2023.03.040.
[8] ZHANG Xitao,SU Pixiong,LIU Yan,et al. Application of emergency coronary artery bypass grafting in acute myocardial infarction[J]. Chinese Journal of Emergency Medicine. 2005;14(4):319-322.
[9] LI Jing, CHENG Long, WANG Heyang, et al. Safety and efficacy of bivalirudin versus unfractionated heparin during perioperative period of percutaneous coronary intervention[J]. Chinese Journal of Cardiology. 2020;48(8):648-654. Doi: 10.3760/cma.j.cn112148-20200717-00566.
[10] Dai ZG. Comparison of effect of early thrombolysis and interventional therapy in acute myocardial infarction[J]. China Practical Medicine. 2023;18(4):1-4. Doi: 10.14163/j.cnki.11-5547/r.2023.04.001.
[11] LI Yanmin, FENG Yan, WEI Yanyun, et al. Predictive value of TRI,SII,CONUT score in the prognosis of acute myo-cardial infarction after percutaneous coronary intervention[J]. Journal of North Sichuan Medical College. 2023;38(7):906-909. Doi: 10.3969/j.issn.1005-3697.2023.07.009.
[12] Wang X. Analysis of the effect of aspirin combined with hydroclopidogrel on cardiac function and inflammatory response in patients with acute myocardial infarction[J]. Modern Diagnosis and Treatment. 2023;34(12):1807-1809.
[13] Gao Liansheng. Effect of aspirin and clopidogrel combined with tirofiban on the efficacy and adverse cardiovascular events in patients with diabetes mellitus with acute myocardial infarction[J]. Contemporary Medical Symposium. 2023,21(17):99-101. DOI:10.3969/j.issn.2095-7629.2023.17.030.
Copyright © 2024 Xingchi Liu, Jianwen Li
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License